JPMorgan Boosts Price Target on Essex Property Trust ESS Amid Strong Apartment Demand
Novartis Lifts FullYear Sales and Profit Guidance Amid Strong Operational Performance
The Secretive Business of Orchid Breeding A DecadeLong Investment with Lucrative Potential
Jim Cramers OnAir Silence Trumps 3700 Stock Trades Expose Potential Conflict of Interest Concerns
Chinas Robot Workforce Strategy Elon Musk Highlights Humanoid Robotics Competition
UK Bank Holiday Heatwave and Travel Disruptions Could Impact Travel Sector
PONY Q4 2025 Earnings Narrowing Losses Beat Estimates as Stock Edges Lower
KFS Q1 2026 Earnings Loss Per Share of 010 Reported Stock Down Slightly
Textron Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction
Marine Products Corporation MPX Q1 2026 Earnings Weak Profitability and Stock Decline Highlight Ongoing Challenges
GOGO Q1 2026 Earnings Profitability Surprises as EPS Beats Estimates
HFWA Q1 2026 Earnings Net Interest Margin Stability Drives Earnings Beat
Hub Cyber Security Warrants HUBCW Edge Higher Amid Thin Trading Hold at Penny Level
Cheetah Net Supply Chain Service Inc CTNT Faces Minor Pullback Holds Above Key Support
SuperCom Ltd SPCB Shows Modest Gains Amid Support Test
American Electric Power AEP Advances 153 as Utility Sector Holds Steady
Excelerate Energy EE Declines 358 as Shares Test Key Support Zone
Michael Saylors MicroStrategy A Potential Shift in Bitcoin Accumulation Strategy
Genpact G Q1 2026 Earnings EPS Beat Drives Investor Focus on Margin Strength
Prudential Financial Junior Subordinated Notes PRS Nears Support as Yields Attract Consideration
JSM Q1 2026 Earnings Navient Beats EPS Estimates by 2225 Note Price Unchanged
Piper Sandler Q1 2026 Earnings EPS Beats Estimates by 512 Amid Mixed Market Signals
SOWG Q3 2025 Earnings Significant EPS Miss Highlights Operational Challenges
ULTA Q1 2026 Earnings EPS Misses Estimates But Stock Gains A Mixed Start to Fiscal 2026
SANUWAVE Health Inc Q1 2026 Earnings Significant EPS Miss Leads to Stock Decline
NGNE Q1 2026 Earnings EPS Falls Short of Consensus as PreRevenue Biotech Maintains RD Focus
CACC Q1 2026 Earnings EPS Slightly Misses Estimates Amid Steady Operations